Gregory Bailey - Net Worth and Insider Trading

Gregory Bailey Net Worth

The estimated net worth of Gregory Bailey is at least $138 Million dollars as of 2023-01-27. Gregory Bailey is the Director of Medivation Inc and owns about 894,660 shares of Medivation Inc (MDVN) stock worth over $73 Million. Gregory Bailey is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 2,583,658 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $36 Million. Gregory Bailey is also the Director of Biohaven Ltd and owns about 1,507,971 shares of Biohaven Ltd (BHVN) stock worth over $28 Million. Details can be seen in Gregory Bailey's Latest Holdings Summary section.

Transaction Summary of Gregory Bailey

To

Gregory Bailey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory Bailey owns 5 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , AgeX Therapeutics Inc (AGE) , and Medivation Inc (MDVN) among others .

Click here to see the complete history of Gregory Bailey’s form 4 insider trades.

Insider Ownership Summary of Gregory Bailey

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2017-05-03 director
AGE AgeX Therapeutics Inc 2018-11-27 director
MDVN Medivation Inc 2012-10-30 director
ACER Acer Therapeutics Inc 2006-04-13 director
BHVN Biohaven Ltd 2022-10-03 director

Gregory Bailey Latest Holdings Summary

Gregory Bailey currently owns a total of 3 stocks. Among these stocks, Gregory Bailey owns 894,660 shares of Medivation Inc (MDVN) as of October 24, 2012, with a value of $73 Million and a weighting of 52.93%. Gregory Bailey owns 2,583,658 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of August 19, 2022, with a value of $36 Million and a weighting of 26.43%. Gregory Bailey also owns 1,507,971 shares of Biohaven Ltd (BHVN) as of October 25, 2022, with a value of $28 Million and a weighting of 20.65%.

Latest Holdings of Gregory Bailey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDVN Medivation Inc 2012-10-24 894,660 81.44 72,861,110
BHVN Biohaven Pharmaceutical Holding Co Ltd 2022-08-19 2,583,658 14.08 36,377,905
BHVN Biohaven Ltd 2022-10-25 1,507,971 18.85 28,425,253

Holding Weightings of Gregory Bailey


Gregory Bailey Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory Bailey has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 33,600 shares on October 24, 2012, which brought Gregory Bailey around $900,480.

According to the SEC Form 4 filings, Gregory Bailey has made a total of 9 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 2 buys and 7 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 38,000 shares on August 19, 2022, which cost Gregory Bailey around $6 Million.

According to the SEC Form 4 filings, Gregory Bailey has made a total of 1 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 200,000 shares on October 25, 2022, which cost Gregory Bailey around $2 Million.

Insider Trading History of Gregory Bailey

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
BHVN
Biohaven Ltd
2022-10-25
Buy
200,000.00
15.29%
$10.50
$2,100,000.00
1,507,971.00
$18.85
79.52%
2022-10-26
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2022-08-19
Buy
38,000.00
1.49%
$148.04
$5,625,520.00
2,583,658.00
$14.08
-90.49%
2022-08-22
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-10-23
Sell
34,969.00
-1.36%
$79.31
$2,773,390.00
2,545,658.00
$14.08
-82.25%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-10-19
Sell
8,302.00
-0.32%
$78.93
$655,277.00
2,580,627.00
$14.08
-82.16%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-10-12
Sell
6,729.00
-0.26%
$78.87
$530,716.00
2,588,929.00
$14.08
-82.15%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-07-08
Sell
50,000.00
-1.89%
$75.22
$3,761,000.00
2,595,658.00
$14.08
-81.28%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-06-24
Sell
105,638.00
-3.84%
$73.98
$7,815,100.00
2,645,658.00
$14.08
-80.97%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2020-06-22
Sell
244,362.00
-8.16%
$71.88
$17,564,700.00
2,751,296.00
$14.08
-80.41%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2019-08-20
Buy
5,000.00
0.19%
$37.65
$188,250.00
2,587,601.00
$14.08
-62.60%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-01-31
Sell
50,000.00
-1.98%
$33.71
$1,685,500.00
2,475,101.00
$14.08
-58.23%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-01-23
Sell
16,000.00
-0.63%
$32.79
$524,640.00
2,525,101.00
$14.08
-57.06%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-01-22
Sell
49,000.00
-1.89%
$30.76
$1,507,240.00
2,541,101.00
$14.08
-54.23%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-01-16
Sell
40,000.00
-1.52%
$26.52
$1,060,800.00
2,590,101.00
$14.08
-46.91%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2018-01-04
Sell
50,000.00
-4.10%
$28.71
$1,435,500.00
1,170,299.00
$14.08
-50.96%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2017-12-20
Sell
39,430.00
-3.13%
$26.31
$1,037,400.00
1,220,299.00
$14.08
-46.48%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2017-11-30
Sell
9,970.00
-0.79%
$25.48
$254,036.00
1,259,729.00
$14.08
-44.74%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2017-11-27
Sell
20,600.00
-1.60%
$25.92
$533,952.00
1,269,699.00
$14.08
-45.68%
-
BHVN
Biohaven Pharmaceutical Holding Co Ltd
2017-05-09
Buy
175,000.00
15.69%
$17.00
$2,975,000.00
1,290,299.00
$14.08
-17.18%
-
MDVN
Medivation Inc
2012-10-24
Sell
33,600.00
-6.99%
$26.80
$900,480.00
894,660.00
$81.44
203.88%
-
MDVN
Medivation Inc
2012-10-16
Sell
6,400.00
-1.36%
$26.75
$171,200.00
928,260.00
$81.44
204.45%
-
Total 39
  • 1
  • 2
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory Bailey Trading Performance

GuruFocus tracks the stock performance after each of Gregory Bailey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory Bailey is 31.87%. GuruFocus also compares Gregory Bailey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory Bailey within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gregory Bailey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gregory Bailey

Average Relative Return

53.91%

Average relative return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 11.47 31.87 27.49 53.91 79.98 46.07
Relative Return to S&P 500(%) 11.18 27.05 15.43 39.3 63.4 35.91

Gregory Bailey Ownership Network

Ownership Network List of Gregory Bailey

No Data

Ownership Network Relation of Gregory Bailey


Gregory Bailey Owned Company Details


Gregory Bailey Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory Bailey. You might contact Gregory Bailey via mailing address: 4 A Chesham Street, London X0 Sw1x8dt.